TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Resonance Health Ltd ( (AU:RHT) ) has provided an update.
Resonance Health Ltd has announced an investor strategy day, inviting stakeholders to join a live webcast hosted by key company executives. The event aims to provide insights into the company’s strategic direction and will be available for later viewing. This initiative underscores Resonance Health’s commitment to transparency and engagement with its stakeholders, potentially strengthening its market position and fostering investor confidence.
More about Resonance Health Ltd
Resonance Health is an Australian healthcare technology and services company that provides globally recognized quantitative assessments for disease management and drug development. The company has achieved regulatory clearances for its Software-as-Medical Devices (SaMDs) in the USA, Europe, UK, and Australia, and holds ISO 13485 certification. Its products, which include FerriScan®, FerriSmart®, HepaFatScan®, HepaFatSmart®, LiverSmart®, and CardiacT2*, are used in non-invasive MRI-based assessments for conditions like iron overload and fatty liver disease.
Average Trading Volume: 396,085
Technical Sentiment Signal: Sell
Current Market Cap: A$19.77M
Learn more about RHT stock on TipRanks’ Stock Analysis page.